Introduction
NSCLC, deaths, Lung cancer
LUNG CANCER, NSCLC
Lung cancer is the leading cause of cancer-related deaths worldwide, with a mortality rate of 18% (Sung et al. Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the recommended first-line treatment strategy for patients with advanced NSCLC harboring the Osimertinib is an oral, irreversible EGFR-TKI that selectively inhibits both 